ImageneBio, Inc.

Contributing Author

Recent Articles by ImageneBio, Inc.

9 hours	ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer IMA GlobeNewswire
Nov-12	ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team IMA GlobeNewswire
Nov-06	ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences IMA GlobeNewswire
Aug-01	ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) IMA GlobeNewswire